JPS6256851B2 - - Google Patents

Info

Publication number
JPS6256851B2
JPS6256851B2 JP54069545A JP6954579A JPS6256851B2 JP S6256851 B2 JPS6256851 B2 JP S6256851B2 JP 54069545 A JP54069545 A JP 54069545A JP 6954579 A JP6954579 A JP 6954579A JP S6256851 B2 JPS6256851 B2 JP S6256851B2
Authority
JP
Japan
Prior art keywords
chloro
naphthoquinone
compound represented
formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54069545A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5511573A (en
Inventor
Eichi Joonzu Goodon
Emu Yangu Jon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of JPS5511573A publication Critical patent/JPS5511573A/ja
Publication of JPS6256851B2 publication Critical patent/JPS6256851B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP6954579A 1978-06-05 1979-06-05 Novel naphthoquinones*their manufacture and medical composition containing them Granted JPS5511573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/912,697 US4229478A (en) 1978-06-05 1978-06-05 Naphthaquinone anti-psoriatic agents

Publications (2)

Publication Number Publication Date
JPS5511573A JPS5511573A (en) 1980-01-26
JPS6256851B2 true JPS6256851B2 (enExample) 1987-11-27

Family

ID=25432288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6954579A Granted JPS5511573A (en) 1978-06-05 1979-06-05 Novel naphthoquinones*their manufacture and medical composition containing them

Country Status (6)

Country Link
US (1) US4229478A (enExample)
EP (1) EP0007985B1 (enExample)
JP (1) JPS5511573A (enExample)
AT (1) ATE1500T1 (enExample)
DE (1) DE2963603D1 (enExample)
ES (1) ES481235A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442127A (en) * 1978-06-05 1984-04-10 Syntex (U.S.A.) Inc. Naphthoquinone anti-psoriatic agents
US4419368A (en) * 1978-06-05 1983-12-06 Syntex (U.S.A.) Inc. Naphthoquinone anti-psoriatic agents
US4466981A (en) * 1982-10-27 1984-08-21 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung
JPS60185745A (ja) * 1984-01-27 1985-09-21 シンテツクス（ユー・エス・エイ）インコーポレイテツド 抗乾癬性ナフタレン化合物
US4562004A (en) * 1984-03-14 1985-12-31 Basf Aktiengesellschaft 2,3,5,6-Tetrasubstituted p-benzoquinones and their preparation
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
US4592867A (en) * 1984-10-19 1986-06-03 Energy Conversion Devices, Inc. Synthesis method for reductant precursor
US5134161A (en) * 1987-03-09 1992-07-28 Syntex (U.S.A.) Inc. Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents
KR880011089A (ko) * 1987-03-09 1988-10-26 허위그 본 모르쯔 건선 치료제로서 유용한 나프탈렌 유도체 및 이의 제조방법
US4786652A (en) * 1987-03-09 1988-11-22 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US4840965A (en) * 1987-07-07 1989-06-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US5849793A (en) * 1997-08-15 1998-12-15 The Picower Institute For Medical Research HIV matrix protein tyrosine position 29 pocket binders
BE1012264A3 (fr) * 1998-11-05 2000-08-01 Solvay Nouvelles naphtalenediones et leur utilisation dans la preparation d' anthracenediones.
US6884797B2 (en) * 2001-03-30 2005-04-26 Robert F. Hofmann Targeted oxidative therapeutic formulation
WO2010005989A1 (en) * 2008-07-09 2010-01-14 Edison Pharmaceuticals, Inc. Dermatological compositions with anti-aging and skin even-toning properties
US20100029784A1 (en) * 2008-07-30 2010-02-04 Hinman Andrew W Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914264A (en) * 1975-01-30 1975-10-21 American Cyanamid Co 2-Lower alkoxy-3-(lower alkylthio)-1,4-naphthoquinone

Also Published As

Publication number Publication date
US4229478A (en) 1980-10-21
ATE1500T1 (de) 1982-09-15
ES481235A1 (es) 1980-02-16
EP0007985A1 (en) 1980-02-20
DE2963603D1 (en) 1982-10-28
JPS5511573A (en) 1980-01-26
EP0007985B1 (en) 1982-09-01

Similar Documents

Publication Publication Date Title
JPS6256851B2 (enExample)
US4225619A (en) Substituted fluoracylresorcinols
KR880002309B1 (ko) 나프탈렌 유도체의 제조방법
FR2638161A1 (fr) Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US3716531A (en) 5-nitro-furfurylidene antimicrobic agents
EP0150831B1 (en) Naphthalene anti-psoriatic agents
US4569945A (en) Diarylindane-1,3-diones, their preparation and use
US3182061A (en) 5-[4-(p-hydroxyphenoxy)phenyl]-5-oxo-3-methylvaleric acid
US4255405A (en) Naphthoquinone anti-psoriatic agents
US3210413A (en) Antihypercholesterolemic agents
US3354201A (en) p-dihydroxybenzene-sulfonate of diethylamine
US4786652A (en) Naphthalene anti-psoriatic agents
US3201475A (en) Bisglyoxalyldiphenyl derivatives
US4442127A (en) Naphthoquinone anti-psoriatic agents
GB2094297A (en) Apovincaminol derivatives
AU617663B2 (en) Naphthalene anti-psoriatic agents
EP0215622B1 (en) Naphthalene anti-psoriatic agents and process for making them
EP0147174B1 (en) Dihydroxybenzaldehyde derivatives as anti-inflammatory agents
JPS6041059B2 (ja) 新規なフエニルプロピオン酸エステル誘導体
US5134161A (en) Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents
EP0103265A2 (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
US3391163A (en) 10, 5-(epoxymethano)-10, 11-dihydro-5h-dibenzo [a, d] cycloheptene-11, 13-dione
US4840965A (en) Naphthalene anti-psoriatic agents
US5091558A (en) Naphthalene anti-psoriatic agents
US5155132A (en) Naphthalene lipoxygenase-inhibiting agents